Probiotics for Frequent Diarrhea

Probiotics are one of the few supplement categories with genuinely strong randomised evidence for a specific, measurable outcome: shortening acute infectious diarrhoea and preventing the diarrhoea that follows a course of antibiotics. The effect is real but modest and strain-specific. Pooled trials show acute episodes resolving roughly a day sooner, and antibiotic-associated diarrhoea occurring in noticeably fewer people when a proven strain is started alongside the antibiotic rather than after symptoms appear. What probiotics are not is a general fix for chronic loose stools. Persistent diarrhoea lasting more than two to four weeks needs a diagnosis first: coeliac disease, inflammatory bowel disease, bile acid diarrhoea, microscopic colitis and infection all masquerade as a sensitive gut.

Two large 2018 paediatric emergency-department trials of Lactobacillus rhamnosus GG found no benefit in children with viral gastroenteritis who were already well hydrated, which tempered earlier enthusiasm. The honest reading is that probiotics help most where the disruption is drug-induced or the illness is more severe, and least where the body would recover quickly anyway. Treat them as a targeted, short-course intervention with a defined goal and an end date, not a permanent daily habit.

Diarrhoea happens when the gut moves water into the lumen faster than it reabsorbs it. Antibiotics and enteric infections both do this by stripping out resident bacteria, which removes competition for nutrients and adhesion sites, reduces fermentation of carbohydrate into absorbable short-chain fatty acids, and disrupts bile acid handling. Probiotic strains work at the margins of that process. They occupy the niche transiently, produce lactate and short-chain fatty acids, tighten epithelial junctions, compete with pathogens for binding sites and modulate local immune signalling. Saccharomyces boulardii, a yeast rather than a bacterium, additionally survives antibiotic exposure and secretes a protease that degrades C. difficile toxin A.

Strain and CFU count matter more than brand. The trials that worked used specific organisms at doses in the billions, started early and continued for a defined window rather than indefinitely. For antibiotic-associated diarrhoea, timing is the single biggest lever: begin on the same day as the antibiotic, take the probiotic two to three hours away from each dose, and continue for one to two weeks after the course finishes.

The prevention evidence is the strongest part of the picture. Systematic reviews of antibiotic-associated diarrhoea in adults find a consistent reduction in incidence, and pooled trials of C. difficile-associated diarrhoea show fewer episodes when probiotics are started early in the antibiotic course, with the caveat that baseline risk in most trial populations was low. For acute gastroenteritis the signal is more mixed. Older pooled analyses reported roughly a day less illness, while the two 2018 multicentre paediatric trials below found no meaningful difference in outpatient children. Severity and setting appear to determine whether the effect is detectable.

In healthy people probiotics are well tolerated. The common complaints are transient bloating, gas and mild cramping in the first few days, which usually settle or resolve with a lower dose. The serious risks concentrate in a narrow group. Bloodstream infection and fungaemia have been reported in people with central venous catheters, severe immunosuppression, short bowel syndrome, acute pancreatitis and critical illness. Saccharomyces boulardii in particular has caused fungaemia in catheterised and critically ill patients.

Probiotics have few pharmacokinetic interactions, but they are living organisms, so anything that kills them or lets them translocate matters. Antibiotics and antifungals are the main practical issues, and separating doses by two to three hours is enough for most combinations.